Recruiting
Investigating the Combination of Bexmarilimab and Nivolumab in Solid Tumours, Melanoma and NSCLC
NCT07718243
- Conditions
- Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +20 more
- Locations
-
- The Christie NHS Foundation Trust Manchester, United Kingdom
- The Royal Marsden NHS Foundation Trust - Drug Development Unit Sutton, United Kingdom